ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼® : Á¦Ç°º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2024-2031³â)
¼¼°è ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð´Â 2022³â 465¾ï ´Þ·¯·Î ¿¹Ãø ±â°£(2024-2031³â) µ¿¾È 8.50%ÀÇ CAGR·Î 2023³â 504¾ï 5,000¸¸ ´Þ·¯¿¡¼ 2031³â 969¾ï ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Ç÷¾Ð, ü¿Â, Ç÷Áß »ê¼Ò ³óµµ¿Í °°Àº Áß¿äÇÑ »ýü µ¥ÀÌÅ͸¦ ÃøÁ¤, ±â·Ï, Ç¥½ÃÇÏ´Â ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¼¼°è ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ÃÖ±Ù ¸î ³â µ¿¾È Å« ÆøÀ¸·Î ¼ºÀåÇß½À´Ï´Ù. ÁÖ¿ä Æ®·»µå´Â º´¿ø Ä¡·á¿¡¼ ÀçÅà ÀÇ·á·ÎÀÇ ÀüȯÀ¸·Î, º¸´Ù Àú·ÅÇÏ°í Ä£±ÙÇÑ Ä¡·á·Î ÀüȯµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ±â¼úÀÇ ¹ßÀü°ú ¸¸¼ºÁúȯÀ» Áý¿¡¼ °ü¸®ÇØ¾ß ÇÏ´Â Çʿ伺ÀÌ °áÇյǾî ÀÌ·¯ÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, COVID-19 ÆÒµ¥¹ÍÀº ÀçÅà ȯÀÚ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» °¡¼ÓÈÇß½À´Ï´Ù. Á¦Á¶¾÷üµéÀº ÀåºñÀÇ Á¤È®¼ºÀ» Çâ»ó½ÃÅ°±â À§ÇØ Ã·´Ü ±â¼ú Çõ½ÅÀ» ÃßÁøÇÏ°í ÀÖÀ¸¸ç, ÀÌ´Â Ä¡·á ¹× ¸ð´ÏÅ͸µ Àåºñ¿¡ ´ëÇÑ Àü ¼¼°èÀûÀÎ ¼ö¿ä Áõ°¡¿Í ÇÔ²² ½ÃÀå È®´ë¿¡ ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù.
¸ñÂ÷
¼Ò°³
Á¶»ç ¹æ¹ý
- Á¤º¸ Á¶´Þ
- 2Â÷¡¤1Â÷ Á¤º¸ Ãâó
- ½ÃÀå ±Ô¸ð ÃßÁ¤
- ½ÃÀå °¡Á¤°ú Á¦ÇÑ
ÁÖ¿ä ¿ä¾à
- ½ÃÀå °³¿ä Àü¸Á
- °ø±Þ ¼ö¿ä µ¿Ç⠺м®
- ºÎ¹®º° ±âȸ ºÐ¼®
½ÃÀå ¿ªÇаú Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ¼ºÀå ÃËÁø¿äÀÎ
- ±âȸ
- ¼ºÀå ¾ïÁ¦¿äÀÎ
- °úÁ¦
- Porters ºÐ¼®
ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®
- ÁÖ¿ä ¼º°ø¿äÀÎ
- °æÀï Á¤µµ
- ÁÖ¿ä ÅõÀÚ ±âȸ
- ½ÃÀå »ýÅ°è
- ±â¼ú ºÐ¼®
- ¹ë·ùüÀÎ ºÐ¼®
- °ø±Þ¸Á ºÐ¼®
- °¡°Ý ºÐ¼®
- ƯÇ㠺м®
- ¹«¿ª ºÐ¼®
- °í°´°ú ±¸¸Å ±âÁØ ºÐ¼®
ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Á¦Ç°º°
- ½ÃÀå °³¿ä
- Ç÷´ç ¸ð´ÏÅ͸µ Àåºñ
- ÀÚ°¡ Ç÷´ç ¸ð´ÏÅ͸µ ±â±â
- ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ ±â±â
- ¿þ¾î·¯ºí Ç÷´ç ¸ð´ÏÅ͸µ ±â±â
- ½ÉÀå ¸ð´ÏÅ͸µ ±â±â
- ECG ±â±â
- À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ(ILRS)
- À̺¥Æ® ¸ð´ÏÅÍ
- MCT ¸ð´ÏÅÍ
- ½º¸¶Æ®/¿þ¾î·¯ºí ECG ¸ð´ÏÅÍ
- ¸ÖƼÆĶó¹ÌÅÍ ¸ð´ÏÅ͸µ ±â±â
- ÀúÁ¤¹Ð ¸ð´ÏÅÍ
- ÁßÁ¤¹Ð ¸ð´ÏÅÍ
- °íÁ¤¹Ð ¸ð´ÏÅÍ
- È£Èí ¸ð´ÏÅ͸µ ±â±â
- »ê¼ÒÆ÷ȵµÃøÁ¤±â
- ÆóÈ°·®°è
- Ä«ÇÁ³ë±×·¡ÇÁ
- ÃÖ´ëÈ£±â·®ÃøÁ¤±â
- ¿Âµµ ¸ð´ÏÅ͸µ ±â±â
- ÇÚµåÇïµå ¿Âµµ ¸ð´ÏÅ͸µ ±â±â
- Ź»ó ¿Âµµ ¸ð´ÏÅ͸µ ±â±â
- ¿þ¾î·¯ºí Áö¼Ó ¸ð´ÏÅ͸µ ±â±â
- ħ½À¼º ¿Âµµ ¸ð´ÏÅ͸µ ±â±â
- ½º¸¶Æ® ¿Âµµ ¸ð´ÏÅ͸µ ÆÐÄ¡
- Ç÷¿ªÇÐ/¾Ð·Â ¸ð´ÏÅ͸µ ±â±â
- Ç÷¿ªÇÐ ¸ð´ÏÅÍ
- Ç÷¾Ð ¸ð´ÏÅÍ
- ÀÏȸ¿ë
- ÅÂ¾Æ ¹× ½Å»ý¾Æ ¸ð´ÏÅ͸µ ±â±â
- ÅÂ¾Æ ¸ð´ÏÅ͸µ ±â±â
- ½Å»ý¾Æ ¸ð´ÏÅ͸µ ±â±â
- ½Å°æ ¸ð´ÏÅ͸µ ±â±â
- ³úÆÄ ÃøÁ¤ Àåºñ
- EMG ¸Ó½Å
- ³ú»ê¼ÒÆ÷ȵµÃøÁ¤±â
- ICP ¸ð´ÏÅÍ
- MEG ¸Ó½Å
- TCD ¸Ó½Å
- üÁß ¸ð´ÏÅ͸µ ±â±â
- µðÁöÅРüÁß ¸ð´ÏÅ͸µ ±â±â
- ¾Æ³¯·Î±× üÁß ¸ð´ÏÅ͸µ ±â±â
- ±âŸ ȯÀÚ ¸ð´ÏÅ͸µ ±â±â
ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°
- ½ÃÀå °³¿ä
- º´¿ø¡¤Å¬¸®´Ð
- ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
- ÀçÅà Äɾî ȯ°æ
- ±âŸ ÃÖÁ¾»ç¿ëÀÚ
ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Áö¿ªº°
- ½ÃÀå °³¿ä
- ºÏ¹Ì
- À¯·´
- µ¶ÀÏ
- ½ºÆäÀÎ
- ÇÁ¶û½º
- ¿µ±¹
- ÀÌÅ»¸®¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- Àεµ
- ÀϺ»
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
- GCC ±¹°¡
- ³²¾ÆÇÁ¸®Ä«°øȱ¹
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
°æÀï »óȲ
- »óÀ§ 5°³»çÀÇ ºñ±³
- ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×(2023³â)
- ÁÖ¿ä ½ÃÀå ±â¾÷ÀÌ Ã¤¿ëÇÑ Àü·«
- ½ÃÀåÀÇ ÃÖ±Ù È°µ¿
- ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À²(2023³â)
ÁÖ¿ä ±â¾÷ °³¿ä
- Dexcom, Inc.(US)
- GE Healthcare(US)
- Philips Healthcare(Netherlands)
- Nihon Kohden Corporation(Japan)
- Boston Scientific Corporation(US)
- Archimed SAS(France)
- Compumedics Limited(Australia)
- Nonin Medical, Inc.(US)
- Biotronik(Germany)
- Schiller AG(Switzerland)
- Senseonics(US)
- Cardiomo(India)
- Vitls(US)
- Neteera(Israel)
- Qardio(US)
- Vivify Health(US)
- Irhythm Technologies, Inc.(US)
- Nihon Kohden Corporation(Japan)
- Cardinal Health(US)
- Merit Medical Systems(US)
ksm
Global Patient Monitoring Devices Market size was valued at USD 46.5 billion in 2022 and is poised to grow from USD 50.45 billion in 2023 to USD 96.9 billion by 2031, growing at a CAGR of 8.50% during the forecast period (2024-2031).
The global patient monitoring devices market has experienced significant growth in recent years, driven by rising demand for devices that measure, record, and display vital biometric data such as blood pressure, temperature, and blood oxygen levels. A key trend is the shift from hospital-based care to homecare, making treatments more affordable and accessible. Advances in medical technology, coupled with the need for managing chronic conditions at home, have further fueled this demand. Additionally, the COVID-19 pandemic accelerated the adoption of at-home patient monitoring solutions. Manufacturers are innovating with advanced technologies to improve device precision, which is contributing to the market's expansion as demand for both therapeutic and monitoring devices increases globally.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Patient Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Patient Monitoring Devices Market Segmental Analysis
Global Patient Monitoring Devices Market is segmented by Product, End User, and region. Based on Product, the market is segmented into Blood Glucose Monitoring Devices, Cardiac Monitoring Devices, Multiparameter Monitoring Devices, Respiratory Monitoring Devices, Temperature Monitoring Devices, Hemodynamic/Pressure Monitoring Devices, Fetal & Neonatal Monitoring Devices, Neuromonitoring Devices, Weight Monitoring Devices, and Other Patient Monitoring Devices. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Global Patient Monitoring Devices Market
Government funding is significantly driving the growth of the global patient monitoring devices market. The expansion of the healthcare industry, fueled by both public and private sector investments, particularly in emerging economies, is creating substantial market opportunities. Additionally, government-led initiatives to improve monitoring capabilities for conditions such as cancer, respiratory diseases, diabetes, and cardiovascular diseases, especially in remote regions, are further fueling market demand. These efforts to enhance healthcare access and quality in underserved areas are expected to play a crucial role in accelerating the adoption of patient monitoring devices, contributing to the market's overall growth trajectory.
Restraints in the Global Patient Monitoring Devices Market
A significant restraint in the global patient monitoring devices market is the ongoing challenge of ensuring data security and privacy. These devices collect sensitive health information, including vital signs, medical history, and treatment data, making them vulnerable to potential breaches. As patient data is highly confidential, it is essential to maintain stringent security protocols to protect against unauthorized access, data leaks, identity theft, and confidentiality violations. Any breach in data security could undermine trust in these devices, hinder market growth, and result in severe legal and financial consequences for manufacturers. Ensuring robust data protection is, therefore, a critical concern for the industry.
Market Trends of the Global Patient Monitoring Devices Market
A key trend in the global patient monitoring devices market is the integration of AI-based algorithms and data analytics, which are enhancing the capabilities of digital health devices. Machine learning algorithms, in particular, hold significant potential by enabling the analysis of large datasets, identifying patterns, and predicting health outcomes. As awareness of digital health technologies and preventive care rises, the demand for these advanced devices continues to grow. The adoption of predictive analytics, powered by complex algorithms, facilitates early detection of health issues, ultimately improving medical delivery and patient outcomes. This trend is accelerating market growth, as more healthcare providers leverage these innovations for better decision-making and proactive care.
Table of Contents
Introduction
- Objectives of the Study
- Definitions
- Market Scope
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Market Overview Outlook
- Supply Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factor
- Degree of Competition
- Top Investment Pockets
- Ecosystem of the Market
- Technology Analysis
- Value Chain Analysis
- Supply Chain Analysis
- Pricing Analysis
- Patent Analysis
- Trade Analysis
- Customer & Buying Criteria Analysis
Patient Monitoring Devices Market by Product
- Market Overview
- Blood Glucose Monitoring Devices
- Self-Monitoring Blood Glucose Devices
- Continuous Glucose Monitoring Devices
- Wearable Glucose Monitoring Devices
- Cardiac Monitoring Devices
- ECG Devices
- Implantable Loop Recorders (ILRS)
- Event Monitors
- MCT Monitors
- Smart/Wearable ECG Monitors
- Multiparameter Monitoring Devices
- Low-Acuity Monitors
- Mid-Acuity Monitors
- High-Acuity Monitors
- Respiratory Monitoring Devices
- Pulse Oximeters
- Spirometers
- Capnographs
- Peak Flow Meters
- Temperature Monitoring Devices
- Handheld Temperature Monitoring Devices
- Table-Top Temperature Monitoring Devices
- Wearable Continuous Monitoring Devices
- Invasive Temperature Monitoring Devices
- Smart Temperature Monitoring Patches
- Hemodynamic/Pressure Monitoring Devices
- Hemodynamic Monitors
- Blood Pressure Monitors
- Disposables
- Fetal & Neonatal Monitoring Devices
- Fetal Monitoring Devices
- Neonatal Monitoring Devices
- Neuromonitoring Devices
- EEG Machines
- EMG Machines
- Cerebral Oximeters
- ICP Monitors
- MEG Machines
- TCD Machines
- Weight Monitoring Devices
- Digital Weight Monitoring Devices
- Analog Weight Monitoring Devices
- Other Patient Monitoring Devices
Patient Monitoring Devices Market by End User
- Market Overview
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Other End Users
Patient Monitoring Devices Market Size by Region
- Market Overview
- North America
- Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2023
- Strategies Adopted by Key Market Players
- Recent Activities in the Market
- Key Companies Market Share (%), 2023
Key Company Profiles
- Dexcom, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nihon Kohden Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Archimed SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Compumedics Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nonin Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biotronik (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Schiller AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Senseonics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardiomo (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vitls (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Neteera (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qardio (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vivify Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Irhythm Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nihon Kohden Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardinal Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merit Medical Systems (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments